The findings add to growing evidence to support the meaningful health benefits of GLP-1 drugs beyond weight loss
Resources We Trust Mayo Clinic: Weight Loss: Gain Control of Emotional Eating Columbia University Irving Medical Center: Why Its Hard to Maintain Weight Loss Obesity Medicine Association: Top Weight Loss Medications Cleveland Clinic: Set Point Theory May Explain Why Youre Not Losing Weight Obesity Action Coalition: What Is Obesity Treatment
The regulatory gap MEDVis business model depends on a narrowing regulatory gap
Coverage may be considered only if the medication receives FDA approval in the future
I think thats just part of the inherent bias towards the treatment of people with obesity, feeling like its cheating or not necessary. The list price for Wegovy is around $1,300 per month, and for Ozempic, around $1,000
Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six teratology information services